Company CVAbout Glenmark Pharmaceuticals Ltd. 
Glenmark Pharmaceuticals Ltd.
Large Cap
Pharmaceuticals & Drugs
Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
Company Coordinates
Company Details
B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road Mumbai Maharashtra : 400026
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 28.22 Cr
Number of Shares
28.22 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
13-Feb-2024
28.22
28.22
20000
1
Issued under ESOP Scheme
02-Feb-2017
28.22
28.22
41875
1
ESOP
02-Feb-2017
28.22
28.22
41875
1
ESOP
14-Jul-2016
28.22
28.22
2000
1
ESOP
14-Jul-2016
28.22
28.22
2000
1
ESOP
12-May-2016
28.22
28.22
8000
1
ESOP
12-May-2016
28.22
28.22
8000
1
ESOP
15-Dec-2015
28.22
28.22
2000
1
ESOP
15-Dec-2015
28.22
28.22
2000
1
ESOP
22-Jun-2015
28.22
28.22
32500
1
ESOP
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 25 Schemes (12.12%)
FIIs
Held by 348 FIIs (23.51%)
Promoter with highest holding
Saldanha Family Trust (45.45%)
Highest Public shareholder
Mirae Asset Large & Midcap Fund (3.55%)
Individual Investors Holdings
12.65%
Board of Directors
Management
Designation
Remuneration
Glenn Saldanha
Chairman / Executive Director
16.18 cr
Cheryl Pinto
Executive Director (Corporate)
4.59 cr
V S Mani
Executive Director & Group CFO
10.25 cr
B E Saldanha
Non Executive Director
4.0 lacs
Rajesh Desai.
Independent Non Exe. Director
17.0 lacs
Devendra Raj Mehta
Independent Non Exe. Director
22.0 lacs
Bernard Munos
Independent Non Exe. Director
5.0 lacs
Brian W Tempest
Independent Non Exe. Director
5.0 lacs
Sridhar Gorthi
Independent Non Exe. Director
15.0 lacs
Sona Saira Ramasastry
Independent Non Exe. Director
13.0 lacs
Dipankar Bhattacharjee
Independent Non Exe. Director
9.0 lacs
V R Iyer
Independent Non Exe. Director
1.0 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
3,388 Cr
(Quarterly Results - Dec 2024)
Net Profit:
348 Cr
Pharmaceuticals & Drugs
INR 38,665 Cr (Large Cap)
158.00
33
0.18%
-0.01
-5.86%
4.60
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
